It is not often that you come across an investment trust that is available for less than half of its net asset value (NAV), but this niche vehicle looks like it is materially undervalued.
Does Biotech Growth Trust’s recent share price weakness offer a decent entry point for long-term investors?
A report by Investec looking at how the UK equity income sector held up during the lockdown has highlighted an advantage of close-ended funds.
Investment trusts have several important structural advantages over their open-ended peers, but they can also be more complicated and with hundreds to choose from it can be difficult to know which ones to buy.
Aberdeen Smaller Companies Income has delivered a benchmark-beating ten year return of over 300%, yet the shares are trading at a much wider discount than its peer group.
The latest addition to this burgeoning investment trust sector will provide access to a proven and differentiated strategy that has delivered attractive, risk-adjusted returns.
Baillie Gifford Japan has an excellent long-term track record, but the recent pullback provides an ideal entry point for this growth-oriented trust.
The Bank of England has warned that markets are at risk if investors start to worry about the prospects of stagflation.
Japan’s economy has struggled for decades to escape from a spiral of low growth and deflation but could it be a haven in an inflationary era?
The £1.7bn investment trust has established an excellent long-term track record and is a core recommendation for the region, despite being affected by the recent Chinese communist party interventions.
